Qiagen (NYSE:QGEN) Shares Acquired by Susquehanna International Securities Ltd.

Susquehanna International Securities Ltd. raised its holdings in shares of Qiagen (NYSE:QGEN) by 9.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,337 shares of the company’s stock after purchasing an additional 13,026 shares during the quarter. Qiagen accounts for approximately 1.4% of Susquehanna International Securities Ltd.’s portfolio, making the stock its 6th largest position. Susquehanna International Securities Ltd. owned about 0.06% of Qiagen worth $6,013,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of QGEN. Toronto Dominion Bank purchased a new position in shares of Qiagen during the second quarter valued at approximately $27,000. Riverview Trust Co bought a new stake in shares of Qiagen in the 1st quarter worth $28,000. Park Place Capital Corp bought a new stake in shares of Qiagen in the 1st quarter worth $36,000. Quarry LP purchased a new stake in shares of Qiagen in the fourth quarter valued at about $38,000. Finally, CWM LLC lifted its position in shares of Qiagen by 19.1% during the first quarter. CWM LLC now owns 2,236 shares of the company’s stock valued at $96,000 after purchasing an additional 358 shares in the last quarter. Institutional investors and hedge funds own 70.00% of the company’s stock.

Qiagen Trading Up 0.5 %

Shares of Qiagen stock opened at $45.23 on Friday. The stock has a market capitalization of $10.32 billion, a P/E ratio of 30.36, a P/E/G ratio of 3.17 and a beta of 0.39. Qiagen has a 52-week low of $34.74 and a 52-week high of $47.44. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.46 and a current ratio of 1.77. The stock’s 50-day simple moving average is $45.20 and its 200 day simple moving average is $43.49.

Qiagen (NYSE:QGEN) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.03. Qiagen had a net margin of 3.75% and a return on equity of 12.92%. The company had revenue of $496.00 million for the quarter, compared to analyst estimates of $495.45 million. During the same quarter in the previous year, the firm posted $0.53 earnings per share. The company’s quarterly revenue was down .2% compared to the same quarter last year. As a group, research analysts anticipate that Qiagen will post 2.15 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on QGEN shares. Wolfe Research upgraded shares of Qiagen from a “peer perform” rating to an “outperform” rating and set a $50.00 price objective for the company in a research note on Thursday, June 27th. JPMorgan Chase & Co. increased their price target on Qiagen from $52.00 to $54.00 and gave the company an “overweight” rating in a research report on Tuesday, June 18th. Finally, Robert W. Baird boosted their price objective on Qiagen from $49.00 to $52.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $51.10.

Qiagen Profile

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories.